Search clinical trials for: everolimus and letrozole

Total 272551 results

Gustave Roussy, Cancer Campus, Grand Paris
Novartis

Unknown

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (RAD001)

Non-small Cell Lung Cancer | Locally Advanced Disease

France
National Cancer Center, Korea

Terminated

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

Metastatic Breast Cancer

Korea, Republic of
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

Carcinoma of Unknown Primary Origin

United States
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Heinrich-Heine University, Duesseldorf

Terminated

Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma (RAD001)

Bladder Cancer

Germany
Maasstad Hospital

Completed

A Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (COMPARE 1)

Acute Coronary Syndrome | Stable Angina | Unstable Angina

Netherlands
Swiss Group for Clinical Cancer Research

Completed

Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer

Breast Cancer

Switzerland
Novartis

Completed

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Breast Cancer

Canada
Fudan University

Unknown

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer (LEANEX)

Breast Cancer

China
University of Kansas

Completed

An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

Breast Cancer

United States
Yantai Yuhuangding Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer

Breast Cancer

China
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery (CAPRA)

Head and Neck Cancer

France
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Herbert Hurwitz, MD
Novartis; Genentech, Inc.; Amgen

Completed

BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) (BEP)

Solid Tumors

United States
Ural State Medical University
Ural Institute of Cardiology; Ural Federal University; De Haar Research Foundation

Terminated

Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting (NANOM PCI)

Coronary Artery Disease | Atherosclerosis

Netherlands, Russian Federation
Hospices Civils de Lyon

Withdrawn

Topical Everolimus in Patients With Tuberous Sclerosis Complex (EVEROST)

Facial Angiofibromas

France
Novartis Pharmaceuticals

Completed

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Lymphangioleiomyomatosis

France, United States, Italy
NYU Langone Health

Completed

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Neurofibromatosis Type 2 | Meningiomas | Vestibular Schwannomas

United States
Novartis Pharmaceuticals

Completed

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Renal Cell Carcinoma

South Africa, Egypt, Saudi Arabia, Russian Federation, Lebanon, Thailand, Jordan, India, Tunisia, Algeria
Mario Negri Institute for Pharmacological Research

Terminated

Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) (ORCHIDEE)

Renal Cell Carcinoma

Italy
iOMEDICO AG
Novartis

Completed

Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2) (MARC-2)

Metastatic Renal Cell Carcinoma | Failure of Exactly One Prior VEGF-targeted Therapy

Germany
Novartis Pharmaceuticals

Withdrawn

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients (HERMES)

Kidney Transplantation

Switzerland
Istituti Ospitalieri di Cremona

Unknown

Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers

Triple Negative Breast Cancer

Italy
Seoul National University Hospital

Completed

Study of RAD001 in Adenoid Cystic Carcinoma (ACCRAD001)

Adenoid Cystic Carcinoma

Korea, Republic of
Hannover Medical School
Novartis

Completed

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer (RADIT)

Testicular Cancer | Germ Cell Cancer

Germany
Queen Mary University of London
Novartis

Completed

Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer (DEVELOP)

Metastatic Clear Cell Renal Cancer

United Kingdom
Austin Health

Unknown

Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol (RADiChol)

Cholangiocarcinoma

Australia
Sheba Medical Center

Unknown

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Prostate Cancer

Israel
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy

Recruiting

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Subclinical Hypothyroidism | Female Infertility | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Egypt
Ahmed Elsayed Aref

Not yet recruiting

Termination of Early Pregnancy in Scarred Uterus With Lletrozole and Misoprostol Compared to Misoprostol Alone

Termination of Early Pregnancy in Scarred Uterus

Egypt
Pfizer

Completed

PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors

Breast Neoplasms

Spain, Korea, Republic of, United States, Australia, Italy, Russian Federation
The University of Hong Kong

Completed

The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual Tissues

Pregnancy

China
University of Virginia
National Cancer Institute (NCI)

Completed

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

Breast Cancer | Osteoporosis

United States
Fudan University

Recruiting

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma | Renal Clear Cell Carcinoma

China
SCRI Development Innovations, LLC
Novartis

Completed

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Breast Cancer

United States
Cairo University

Completed

Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Egypt
University of Zurich
Novartis; Swiss National Science Foundation

Completed

Controlled Level EVERolimus in Acute Coronary Syndromes (CLEVER-ACS)

Acute Coronary Syndromes

Switzerland, Germany
Novartis Pharmaceuticals

Completed

Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency

Hepatic Insufficiency

Germany, Russian Federation, Singapore
Dana-Farber Cancer Institute
Novartis; Brigham and Women's Hospital

Completed

Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia

Waldenstrom's Macroglobulinemia

United States
UMC Utrecht

Completed

A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03) (CPCT-03)

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands
Radboud University Medical Center

Completed

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study) (SPOT)

Renal Cell Carcinoma | Breast Cancer

Netherlands
Jochen Roessler
Clinical Trials Unit Freiburg

Withdrawn

Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome (EPASOS)

Segmental Overgrowth Syndrome

Germany
Novartis Pharmaceuticals

Completed

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small-cell Lung Carcinoma

United States
Novartis Pharmaceuticals

Completed

RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe (MACS0460)

Adenocarcinoma | Carcinoma | Renal Cell | Non Clear Cell Renal Carcinoma | Papillary Cell Renal Carcinoma

France, Italy, Belgium, Germany, Spain, Poland
National Cancer Institute, Slovakia

Completed

Everolimus in Refractory Testicular Germ Cell Cancer

Germ Cell Tumor

Slovakia
Novartis Pharmaceuticals

Completed

Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor (\MACS1304)

Lung Neuroendocrine Neoplasm

China
Ratchavithi Hospital

Unknown

Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma (CRAD001T)

Cholangiocarcinoma
Medical College of Wisconsin

Withdrawn

Myfortic in High MELD Liver Transplantation

High Model for End-Stage Liver Disease (MELD) Score

United States
Abbott Medical Devices

Completed

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan

Search clinical trials for: everolimus and letrozole

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations